Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TBD Pharmatech (formerly TBD-Biodiscovery) is an Estonian contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients (APIs) and fine chemicals. Founded in 2006 as a spin-off from the University of Tartu, the company provides a full range of services from route scouting and process development to GMP manufacturing and regulatory support. Their expertise includes complex organic synthesis, particularly in the areas of anthracyclines, peptidomimetics, and ADC payloads. TBD Pharmatech operates two GMP-certified facilities in Tartu, Estonia, serving pharmaceutical and biotech clients globally in both human and veterinary medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TBD Biodiscovery.